RecallDepth
Class II Ongoing

Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
November 13, 2025
Posted
December 17, 2025
Recall Number
D-0220-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
32736 vials
Firm Location
Naples, FL, United States

Reason for Recall

Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

Distribution

FL, MA, MI & OH

Lot / Code Info

Lot #: WB00006, Exp 12/31/2026

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls